These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21442202)

  • 1. Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - Results from a pilot study.
    Hoke M; Dieckmann K; Koppensteiner R; Schillinger M; Marosi C; Mlekusch W
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):199-203. PubMed ID: 21442202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
    Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
    Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy.
    Navone SE; Guarnaccia L; Locatelli M; Rampini P; Caroli M; La Verde N; Gaudino C; Bettinardi N; Riboni L; Marfia G; Campanella R
    World Neurosurg; 2019 Jan; 121():e621-e629. PubMed ID: 30292037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
    J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
    Xi J; Hassan B; Katumba RGN; Khaddour K; Govindan A; Luo J; Huang J; Campian JL
    BMC Cancer; 2021 Mar; 21(1):285. PubMed ID: 33726710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
    Desch A; Gebhardt C; Utikal J; Schneider SW
    Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
    Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
    Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
    Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
    Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
    Zhang C; Jia Y; Jia Y; Zhang X; Li K
    Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
    Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
    J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated preoperative plasma D-dimer level is an independent prognostic factor for pediatric patients with Wilms tumor.
    Qu Y; Wang H; Wu X; Wang X; Liu W; Wu R
    J Cancer Res Ther; 2024 Aug; 20(4):1195-1200. PubMed ID: 39206981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients.
    Uzum Y; Salman T; Oflazoglu U; Yildiz Y; Varol U; Aysin M; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    Bratisl Lek Listy; 2024; 125(8):463-467. PubMed ID: 38989745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
    Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
    Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.